A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
ConditionCrohn Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSoroka University Medical Center
About this trial
Psychological intervention by COBMINDEX application to reduce psychological stress among CD patients, fatigue and pain and improve the patients' well being, quality-of-life and disease-coping skills, as well as improvement of the patients' immunological profile and intestinal microbiome.
Eligibility criteria
Qualifiers
Willingness to participate and signed informed consent
Hebrew-speaking
Age 18-75
Proven diagnosis of Crohn's disease, at least 3 months post-diagnosis
Disqualifiers
Diagnosis of ulcerative colitis or unclassified inflammatory bowel disease
Planned surgery for Crohn's disease
Surgery for Crohn's disease (excluding drainage of perianal abscess) in the last 3 months
Psychiatric disease (schizophrenia, major depression or bipolar disorder)
Trial design
Treatments tested in this trial
- COBMINDEX digital application
- Human therapist (Control)
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Soroka University Medical Center
Lead sponsor
The Leona M. and Harry B. Helmsley Charitable Trust
Collaborator
Ben-Gurion University of the Negev
Collaborator
Source ClinicalTrials.gov